Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT00486720
Eligibility Criteria:
Inclusion Criteria:
Patient is a male or female, at least 18 years of age with low or intermediate-1 risk Myelodysplastic Syndrome (MDS) defined by the International Prognostic Scoring System
* Patient has previously untreated disease, or has received up to one prior treatment regimen for lower-risk Myelodysplastic Syndrome
* Patient has a performance status of equal to or less than 2 on the Eastern Cooperative Oncology Group Performance Scale
* Patient must have adequate organ function
Exclusion Criteria:
* Patient has clinical evidence of Central Nervous System (CNS) leukemia
* Patient is pregnant or breastfeeding, or expecting to conceive within the projected duration of the study
* Patient had prior treatment with a histone deacetylase inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00486720
Study Brief:
Protocol Section:
NCT00486720